Literature DB >> 2956911

Tissue-type plasminogen activator.

H R Lijnen, D Collen.   

Abstract

Tissue-type plasminogen activator (t-PA) is a serine protease with a molecular weight of about 70,000. It activates plasminogen to plasmin by cleavage of the Arg 560-Val 561 peptide bond. Kinetic analysis showed that the activation obeys Michaelis-Menten kinetics and that the presence of fibrin strikingly enhances the activation rate. The directed action of plasmin towards fibrin in vivo can be explained by the low Michaelis constant in the presence of fibrin (0.16 microM) which allows efficient plasminogen activation on a fibrin clot, while its high value in the absence of fibrin (65 microM) prevents efficient activation in plasma. Plasmin formed on the fibrin surface is protected from rapid inactivation by alpha 2-antiplasmin. Studies on the thrombolytic properties of t-PA (purified from melanoma cell cultures or obtained by recombinant DNA technology) in various animal models and in selected patients revealed that t-PA is a specific thrombolytic agent which induces thrombolysis without causing extensive systemic activation of the fibrinolytic system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956911

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  6 in total

Review 1.  Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.

Authors:  Ali Ehsan Sifat; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  AAPS J       Date:  2017-05-08       Impact factor: 4.009

2.  Expression of high levels of human tissue plasminogen activator in yeast under the control of an inducible GAL promoter.

Authors:  E Martegani; N Forlani; I Mauri; D Porro; W D Schleuning; L Alberghina
Journal:  Appl Microbiol Biotechnol       Date:  1992-08       Impact factor: 4.813

3.  Case series of post-thrombolysis patients undergoing hemicraniectomy for malignant anterior circulation ischaemic stroke.

Authors:  A Williams; M Sittampalam; N Barua; A Mohd Nor
Journal:  Cardiovasc Psychiatry Neurol       Date:  2011-04-18

4.  Accurately cleavable goat β-lactoglobulin signal peptide efficiently guided translation of a recombinant human plasminogen activator in transgenic rabbit mammary gland.

Authors:  Rui Lu; Ting Zhang; Shaozheng Song; Minya Zhou; Lei Jiang; Zhengyi He; Yuguo Yuan; Tingting Yuan; Yaoyao Lu; Kunning Yan; Yong Cheng
Journal:  Biosci Rep       Date:  2019-06-28       Impact factor: 3.840

5.  Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.

Authors:  Shaheen E Lakhan; Annette Kirchgessner; Deborah Tepper; Aidan Leonard
Journal:  Front Neurol       Date:  2013-04-03       Impact factor: 4.003

Review 6.  A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia.

Authors:  Yasuhiro Suzuki; Nobuo Nagai; Kazuo Umemura
Journal:  Front Cell Neurosci       Date:  2016-01-25       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.